Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Interest Expense Over TimeExpanding
Percentile Rank93
3Y CAGR+19.6%
Studio
Year-over-Year Change

Interest expense on outstanding debt

3Y CAGR
+19.6%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$8.80M+14.6%
2025$7.68M-29.8%
2024$10.94M+112.5%
2023$5.15M-
2022$0.00-
2021$0.00-
2020$0.00-
2019$0.00-100.0%
2018$4.85M+12030.0%
2017$40000.00-